Overview of Current Treatment Strategies in Prostate Cancer
- 29 February 2004
- journal article
- Published by Elsevier BV in European Urology Supplements
- Vol. 3 (1), 2-7
- https://doi.org/10.1016/j.eursup.2003.12.002
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Phase II Study of Abarelix Depot for Androgen Independent Prostate Cancer Progression During Gonadotropin-Releasing Hormone Agonist TherapyJournal of Urology, 2003
- Radiation therapy after radical prostatectomy: A review of the issues and optionsSeminars in Radiation Oncology, 2003
- Does hormonal manipulation in conjunction with permanent interstitial brachytherapy, with or without supplemental external beam irradiation, improve the biochemical outcome for men with intermediate or high-risk prostate cancer?BJU International, 2003
- A Randomised Comparison of Bicalutamide ('Casodex') 150 mg versus Placebo as Immediate Therapy Either Alone or as Adjuvant to Standard Care for Early Non-Metastatic Prostate Cancer First Report from the Scandinavian Prostatic Cancer Group Study No. 6European Urology, 2002
- ROLE OF EARLY ADJUVANT HORMONAL THERAPY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCERJournal of Urology, 2001
- Treatment Options in Hormone-Refractory Prostate CancerDrugs, 2001
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerThe New England Journal of Medicine, 1999
- Intermittent versus continuous hormone deprivation in metastatic prostate cancer: preliminary data from an ongoing European studyProstate Cancer and Prostatic Diseases, 1999
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinThe New England Journal of Medicine, 1997
- Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate CancerJournal of Urology, 1995